Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 59.20M P/E - EPS this Y 74.70% Ern Qtrly Grth -
Income -18.07M Forward P/E -2.29 EPS next Y 24.00% 50D Avg Chg -34.00%
Sales 40k PEG - EPS past 5Y - 200D Avg Chg -15.00%
Dividend N/A Price/Book 26.67 EPS next 5Y - 52W High Chg -52.00%
Recommedations 2.00 Quick Ratio 0.75 Shares Outstanding 16.28M 52W Low Chg 219.00%
Insider Own 30.77% ROA -326.50% Shares Float 11.56M Beta 0.65
Inst Own 0.04% ROE -6,342.03% Shares Shorted/Prior 461.70K/0.96M Price 0.80
Gross Margin 100.00% Profit Margin - Avg. Volume 763,230 Target Price 2.50
Oper. Margin -40,707.69% Earnings Date Nov 11 Volume 397,597 Change -7.03%
About BioSig Technologies, Inc.

BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BioSig Technologies, Inc. News
11/13/24 BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
02:13 PM BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel
08/01/24 BioSig intends to acquire Neuro-Kinesis’ assets
07/31/24 BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
07/25/24 BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024
06/10/24 BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
05/30/24 BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
05/30/24 BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
05/21/24 BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
05/03/24 BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
04/30/24 BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
04/04/24 BioSig Engages Consulting Firm for Business Model Strategies
02/20/24 BioSig Announces Reduction of its Workforce
02/06/24 BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
01/31/24 BioSig Announces Reverse Stock Split
01/30/24 BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
12/12/23 Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
12/06/23 BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
BSGM Chatroom

User Image TheMalekan Posted - 1 week ago

$BSGM load and hold

User Image Stocks7961 Posted - 1 week ago

$BSGM Amato allowed Londoner to sell shares that Biosig should have clawed back. Watch what happens to Amato’s compensation plan

User Image Stocks7961 Posted - 1 week ago

$BSGM Amato is a self dealing scammer, the board violated fiduciary duties, watch and learn. He is Londoner version 2.0 More coming

User Image imagemax Posted - 1 week ago

$BSGM WTF is going on here? What direction does this go? Another major crash coming?

User Image LinkupInvest Posted - 1 week ago

$BSGM Short term oversold RSI.

User Image LinkupInvest Posted - 1 week ago

$BSGM BioSig Technologies (BSGM) regained compliance with Nasdaq's minimum bid price requirement.

User Image fastmoneytraderz Posted - 1 week ago

shorted $BSGM 1.76 covered 1.58

User Image KUMU Posted - 1 week ago

$BSGM went short here

User Image _www_larval_com_ Posted - 1 week ago

$BSGM has stumbled -21% lower to -21% (~170Kv) a few minutes ago, 01/17 options, follow for more volatility.

User Image debbiekatz Posted - 1 week ago

$bsgm gets the double today hitting 2.25. on last weeks bottom list at 1.1 for 103% gain. posted in here at 1.65 for 36% gain.

User Image debbiekatz Posted - 1 week ago

$bsgm waiting for double on this one at 2.2 now. on last weeks bottom list at 1.11. posted here at 1.65.

User Image Stocks7961 Posted - 1 week ago

$BSGM Part -8 Biosig’s board was noticed of Amato’s security law violations and common law fraud claims made here, they were requested to remove Amato. The crony board violated their fiduciary duty to shareholders. The crony board is now being noticed that if they allow Amato to sell any shares more charges will be added against them. The Securities and Exchange Commission will be looking at this and a derivative suit to strip Amato of his compensation package is being filed based on his security disclosure violations, fraud and complete lack of ethics. Coming soon, Londoners and his crony boards scam and why Amato didn’t take action against them.

User Image Stocks7961 Posted - 1 week ago

$BSGM Part 7 - I again did not accept that shady offer. I contacted Nuero Kinesis CEO Josh Shachar and he informed me Amato did not disclose to him my settlement offer, or that I would be issued 750,000 shares after the deal closed. No surprise there. for libel and disclosing inside information. You can guess my response. Next, after sending me that laughable litigation threat, through a third party, Amato upped my cash settlement to $175,000 plus 1.75 million shares. Biosig stock increase is do to its value as a merger candidate for being in Nasdaq. It has nothing to do with the crony board or Amato.

User Image Stocks7961 Posted - 1 week ago

$BSGM Part -6 - Amato had an attorney then send me a letter he was suing me Part 5 - At that meeting, he also stated that Donohoe lied to him, that both Sichenzia and Donohoe were negligent but he was still paying them. Amato offered to up my settlement to 1 million 750 thousand shares and $50,000 cash for not suing. Amato told me the board approved 600,000 shares consulting, I would get 400,000 shares from a third party and he would give me 750,000 shares for helping with the Nuero Kinesis deal. He had to do it that way because he had had already sent the cap structure Nuero Kinesis. I did not know Nuero Kinesis nor did I help with anything. After that meeting Biosig gave the the utterly corrupt Amato that insane compensation package, currently valued at $ 7 mil. They knew that would be the value because Amato repeatedly stated $1.91 was the Nuero deal.

User Image Stocks7961 Posted - 1 week ago

$BSGM Part 5 - At that meeting, he also stated that Donohoe lied to him, that both Sichenzia and Donohoe were negligent but he was still paying them. Amato offered to up my settlement to 1 million 750 thousand shares and $50,000 cash for not suing. Amato told me the board approved 600,000 shares consulting, I would get 400,000 shares from a third party and he would give me 750,000 shares for helping with the Nuero Kinesis deal. He had to do it that way because he had had already sent the cap structure Nuero Kinesis. I did not know Nuero Kinesis nor did I help with anything. After that meeting Biosig gave the the utterly corrupt Amato that insane compensation package, currently valued at $ 7 mil. They knew that would be the value because Amato repeatedly stated $1.91 was the Nuero deal. I again did not accept that shady offer. I contacted Nuero Kinesis CEO Josh Shachar and he informed me Amato did not disclose to him my settlement offer, or that I would be issued 750,000 shares.

User Image Stocks7961 Posted - 1 week ago

$BSGM Part 4 - Amato repeatedly stated he wasn’t not looking back. Amato told me he couldn’t do anything about the millions of dollars investors lost from his negligence, while stating it was Donahoe and Sichenzia’s fault. Amato, and Amato’s crony board members next put his self dealing nefarious plan in action. Amato announced a potential merger with a private company called Nuero Kinesis. After that announcement I met Amato in New Jersey. Amato stated that he wasn’t not suing the attorneys, that he didn’t want to be CEO and when the Nuero Kinesis deal went through he would be stepping down. Amato previously told me he wanted to pursue furthering his private company and the Nuero Kinesis deal would bankroll it.

User Image Stocks7961 Posted - 1 week ago

$BSGM Part 3 -As previously posted, attorneys David Donahoe and Gregory Sichenzia were on a phone call in which Amato told me Donahoe informed him and others that the Nasdaq committee informed him they accepted Biosig’s plan to cure MVLS. Amato was grossly negligent not verifying this with Nasdaq. I repeatedly told Amato that as CEO, he needed to be on every call with Nasdaq. As I previously posted, Amato and the board should have halted the trading and informed Nasdaq of this. Within 48 hours I informed Amato that Nasdaq violating its own rule not giving Biosig proper notice or an automatic 6 month cure period. At first, Amato stated Biosig was going to sue Donohoe and Sichenzia. Amato next stated that he wasn’t going to sue because he was afraid Donohoe would counter sue him. Amato was informed that the phone call in which he claimed Donohoe made those representations was recorded.

User Image Stocks7961 Posted - 1 week ago

$BSGM Part 2 - Amato told me he wanted to become CEO and try to get shareholders back their losses. Adjusted for the reverse split investors I know were bilked paying over $40 a share not knowing what a criminal enterprise Biosig was. Amato asked me to hold off on litigation, he would settle with investors and the company would also sue the past directors. He asked me to stay on as a consultant, our company was paid $50k. Amato, for different reasons, Amato turned out to be just as big of a fraud and self serving weasel skank as Londoner. As previously posted, despite being told he was committing fraud and violating security disclosure laws Amato did not care that his gross negligence caused Biosig shareholders millions if not tens of millions of dollars

User Image Stocks7961 Posted - 1 week ago

$BSGM Part 1 - Prior to Amato becoming CEO he contacted me regarding a litigation hold notice i sent to Biosig. On Saturday February 16 2024 I sent Londoner 2 videos informing him I was moving forward with suing Biosig, Londoner, Laidlaw executive Patrick Gallagher, former Nasdaq vice chair David Weild, Fred Hrvak, Donald Foley, James Barry and James Klein. In February 19th and 20th all of the above directors resigned. Notably, Gallagher worked for Laidlaw when repeatedly financed Legislation Omer with highly dilutive transactions. They tried to tank the company, I informed Nasdaq of this. I will explain why these directors were facing serious legal issues in a future post., the corruption from these crony directors is mind boggling. Biosig’s auditor, Markum, has also received a litigation hold notice.

User Image GetKevin Posted - 1 week ago

$BSGM found this a couple weeks ago and it’s already doubled. Been in a steady uptrend ever since. Looking for $3.50-$4 this week. High risk, high reward. If this thing gets some volume…🚀

User Image Stocks7961 Posted - 1 week ago

$BSGM in addition to the fraud and securities violations,Biosig’s board of directors are also being sued for giving Amato an obscene compensation package. The compensation was obscene as a standalone, but the crony board of directors knew that they and Amato defrauded investors by concealing material news and then engaged in self dealing. The actions by Amato and the board caused millions, maybe 10 million dollars in losses to investors. Wouldn’t be surprised to see SEC action taken against Amato disgorging him of compensation and criminal actions taken against Londoner.

User Image 4UJOHNNY Posted - 1 week ago

$BSGM

User Image debbiekatz Posted - 2 weeks ago

waiting for the next doubler $bsgm now at 1.94. on this weeks bottom list at 1.11 for 75% gain so far. posted here at 1.65 for 18% gain so far.

User Image Stocks7961 Posted - 2 weeks ago

$BSGM Biosig’s crony board of directors and know all these facts plus much more, yet granted Amato a pay raise, 2.4 million options at .44 and 1.6 million shares. Currently the value of Amato’s compensation package is approximately $6 million dollars! The company is a shell with no sales. Amato committed common law fraud and defrauded investors in his capacity as CEO. He was grossly negligent handling the NASDAQ issues, and may have misled them. He violated federal securities laws. The Biosig $3 million dollar prospectus states that Pure EP is a business when he told me and others that he is liquidating all the equipment and it is not a viable business. Biosig board members are subject to SEC rules and regulations. They may be under the false illusion that they can sit around drinking coffee and stuffing their faces with donuts rubber stamping Amato’s negligent and unlawful acts, but they would be wrong. They are about to be sued.

User Image Stocks7961 Posted - 2 weeks ago

$BSGM prior to the Nasdaq delisting, Amato offered me a settlement of 1 million shares, not to sue Biosig for the actions of Londoner and the previous board of directors. However, I did not sign or agree to that settlement because Amato wanted to classify the shares as 600,000 for consulting and 400, 000 from another party. He wanted to conceal the settlement from Nasdaq and even fraudulently wrote in SEC filings that my potential lawsuit had no merit!

User Image Stocks7961 Posted - 2 weeks ago

$BSGM Amato first told me he was suing Sichenzia and Donohoe, but then told me he was not going to protect shareholders by suing the attorneys because he was afraid of being counter sued. Amato not only violated fiduciary duties but committed fraud by concealing the facts he was duty bound to disclose to shareholders. I contacted Biosig board members and informed them they were going to be sued along with Amato and Biosig. More on the crony directors next week! Amato’s plan was to exit the company reverse merging with Nuero Kenisis while screwing over shareholders. More next week! This could be a book!

User Image Stocks7961 Posted - 2 weeks ago

$BSGM On May 28th 2024 CEO Amato texted me “Nasdaq Approved” Nasdaq then delisted Biosig shares for failing to meet MVLS requirements. Amato texted me Nasdaq approved because he stated to me that his consultant, David Donohoe, represented to him that he just got off the phone with the Nasdaq panel and they approved Biosig’s plan to cure MVLS. Amato did not know that Donohoe was an attorney. Amato was grossly negligent and did not confirm this with Nasdaq. I repeatedly warned Amato to be on the calls with Nasdaq. Amato should have halted trading in Biosig stock and notified Nasdaq immediately. Amato stated to me that Donohoe told him Nasdaq could do whatever they want. Next I informed Amato that lawyers Donohoe and Sichenzia were negligent. Amato told me he blamed Sichenzia. Amato screwed investors out of millions of dollars, then his crony board granted him 1.55 million shares and 2.4 million options at .44

User Image aj_ Posted - 2 weeks ago

$BSGM $CYCC $ONCSQ $SRTS $TLPH someone tell chatstupidGPT that ACRX doesn’t exist anymore. LMAO get the hell out of here.

User Image Stocks7961 Posted - 2 weeks ago

$BSGM Getting asked what did Amato conceal. First, it was not just Amato, it was Amato and his crony board of directors. Second, Amato concealed that his gross negligence in handling the Nasdaq delisting notice, (1) caused the delisting and (2) caused stockholders that sold shares on delisting news, to incur millions of dollars in losses. If Amato and the Board of Directors announced the facts leading up to the delisting on the morning Biosig was delisted, the Nasdaq delisting error would have been resolved much sooner and stockholders might not have sold. Third, the attorneys that Amato hired, Sichenzia and Donohoe did not either know or inform Nasdaq that Biosig was entitled to (1) notice and (2) an automatic 6 month cure period. I informed Amato of that after the delisting. Fourth, Amato and the crony Board of Directors next took advantage of the depressed stock price by granting themselves millions of shares in cheap options. Biosig has no business to speak of.

User Image Stocks7961 Posted - 2 weeks ago

$BSGM Fun Fact: Amato hired a lawyer to threaten me with a lawsuit for libel. Take a guess at my response. I warned Amato repeatedly about his duty to disclose material facts CRIMINAL RESOURCE MANUAL CRM 500-999 914. Concealment--Failure to Disclose Although 18 U.S.C. § 1001 is often referred to as a false statement statute, its scope extends beyond statements. The statute proscribes the acts of making false statements, falsifying, concealing or covering up. The statute also covers half-truths if there is a duty to speak the truth. See generally United States v. Lutwak, 195 F.2d 748 (7th Cir. 1948), aff'd, 344 U.S. 604 (1953).

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Jun 12 Buy 1.17 6,000 7,020 2,491,420 06/12/23
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Sep 07 Buy 0.91 7,250 6,598 1,844,354 09/08/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Sep 02 Buy 1.04 12,300 12,792 1,837,806 09/07/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Sep 01 Buy 1.0849 17,240 18,704 1,824,804 09/02/22
CHAUSSY STEVE Chief Financial Offi.. Chief Financial Officer Sep 01 Buy 1.1316 11,425 12,929 1,051,553 09/02/22
Sieckhaus John Chief Operating Offi.. Chief Operating Officer Aug 30 Buy 1.067 5,000 5,335 65,000 09/01/22
Fleming Gray Chief Commercial Off.. Chief Commercial Officer Aug 24 Buy 1.18 36,036 42,522 36,036 08/31/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Aug 29 Buy 1.08 17,850 19,278 1,807,564 08/31/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Aug 25 Buy 1.14 16,726 19,068 1,789,714 08/29/22
Sieckhaus John Chief Operating Offi.. Chief Operating Officer Aug 24 Buy 1.1347 10,000 11,347 60,000 08/25/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Aug 23 Buy 1.1 12,000 13,200 1,772,988 08/24/22
CHAUSSY STEVE Chief Financial Offi.. Chief Financial Officer Aug 22 Buy 1.127 8,000 9,016 1,040,128 08/24/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Aug 19 Buy 1 10,000 10,000 1,760,988 08/22/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Aug 17 Buy 0.92 13,100 12,052 1,750,988 08/19/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Aug 16 Buy 0.89 25,100 22,339 1,737,888 08/17/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer May 25 Buy 1.15 9,300 10,695 1,712,788 05/26/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer May 24 Buy 1.0980 8,744 9,601 1,703,488 05/25/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer May 20 Buy 1.14 15,500 17,670 1,694,744 05/24/22
LONDONER KENNETH L Chief Executive Offi.. Chief Executive Officer Sep 02 Buy 3.1 5,600 17,360 1,710,658 09/02/21
ODONNELL JEFFREY F Director Director Feb 09 Sell 5.06 105,000 531,300 151,629 02/09/21